Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

Cladribine added to daunorubicin-cytarabine induction prolongs survival of FLT3-ITD+ normal karyotype AML patients

Blood (2016) 127 (3): 360–362.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals